Bank of Montreal vs Charles River Laboratories Intl. Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B). The key difference: Bank of Montreal is far larger — about 9.4× Charles River Laboratories Intl. Inc's market cap, and Bank of Montreal pays a 2.69% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| BMO | CRL | |
|---|---|---|
Market Cap | $126.83B | $13.46B |
Sector | Financials | Health |
52-Week High | $183.65 | $282.00 |
52-Week Low | $112.54 | $145.57 |
Dividend Yield | 2.69% | — |
Enterprise Value | — | $16.30B |
Trailing returns across standard periods
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →